The wound care provider filed the suit for allegedly falsifying and misleading consumers with clinical data.

These stocks look ready to break out and trade higher from current levels.

Trade-Ideas LLC identified Osiris Therapeutics (OSIR) as a weak on high relative volume candidate

Cramer says Osiris Therapeutics is exciting, Opko Health is a buy and you can't go wrong with PPG Industries.

Markets weren't as overheated today, Cramer says. You can buy stocks at great prices if you are patient.

The electric vehicle manufacturer has a very popular industry in its sights despite often low margins.

Here's why people are freaking out about the latest Trader treat.

Cut costs with these Memorial Day gasoline-saving tips

Toll Brothers earned $1.85 a share in its fiscal second quarter on 18% higher revenue.